Case Report
Primary Sjögren’s Syndrome Accompanied by Clinical Features of TAFRO Syndrome
Table 2
Comparison summary of previous cases of Sjögren’s syndrome complicated with clinicopathologic features of TAFRO syndrome.
| Authors | Iwanaga et al. | Fujimoto et al. | Takasawa et al. | Li et al. | Kojima et al. | Our case |
| Sjögren’s syndrome | Histopathology | + | + | ND | ND | ND | ND | Oral examination | + | Scintigraphy | ND | ND | ND | + | Ocular examination | + | + | + | ND | ND | − | Anti-Ro/SS-A antibody | + | + | + | + | + | + | Anti-La/SS-B antibody | − | + | − | ND | + | + | TAFRO syndrome | Major categories | Anasarca | + | + | + | + | + | + | Thrombocytopenia | + | + | + | + | + | + | Systemic inflammation | + | + | + | + | + | + | Minor categories | Histology of lymph node biopsy | − | + | + | + | + | ND | Reticulin myelofibrosis | + | + | + | + | ND | − | Mild organomegaly | + | + | + | + | + | + | Renal insufficiency | − | + | + | + | ND | ± | Treatments | PSL, CyA | PSL | PSL, CyA | Siltuximab, PSL, RTX, CY, vincristine | PSL | PSL, CyA, eltrombopag |
|
|
CY, cyclophosphamide; CyA, cyclosporine; PSL, prednisolone; RTX, rituximab; ND, not determined.
|